Our Review Process: How Visivraes Writes and Checks Each Visivra Page

Visivraes is the USA Authorized Visivra Retailer, working from 5 Times Square in New York. It sells the capsules through the seller’s checkout and keeps this website. It did not formulate Visivra, it does not manufacture it, and it has no laboratory of its own, so everything this site says has to come from a document a reader could also look at.

The writing is done by the Visivra Team, the in-house desk that signs every page. The team reads the label artwork, the seller’s product page and the batch paperwork, then looks up every study it intends to cite before a sentence about it is drafted.

Medical accuracy is checked by Dr. Steven Christiansen, MD, a physician, before a page is published. The reviewer is named in the byline under each page title and in the review record at the foot of the page, and the about page carries the reviewer profile. Where a page predates the review, it is brought into the same process the next time it is revised.

1. Transcribe. The writer copies the lines the page needs straight from the artwork: names, count, the four support statements.
2. Date the commercial facts. Prices, pack sizes, shipping and the guarantee are read from the seller’s page with the date printed, and checked against the live checkout before a price page goes up.
3. Look up each study. Every trial named on a page is opened, the amount and the population are read from the record, and the link sits in the sentence that uses it.
4. Write for the reader. The answer to the page title comes first, in plain English. A figure the seller has not published is called unpublished rather than guessed.
5. Medical review. Dr. Steven Christiansen, MD reads the draft for accuracy and safety, with extra attention to vitamin A, zinc, smoking and anything that touches a change in sight.
6. Publish with a date. The page goes up with the reviewer in the byline, the review record at the foot and a revision date that moves only when the content does.

The pack makes four support statements, and they are the ceiling for every page here: support visual clarity, promote healthy retinal function, maintain long-term eye wellness, and help defend the eyes from blue light exposure. Pages describe them as goals the capsule is made to support, not as results.

• No page calls Visivra a treatment or a cure for macular degeneration, cataracts, glaucoma, diabetic eye disease or any other condition.
• No page presents Visivra as the AREDS2 formula or borrows that trial’s findings for it.
• The seller’s page adds mechanism claims about antioxidant defences and ocular circulation; they stay off this site because they are not on the pack.
• No page calls the FDA-registered facility mark an approval. The FDA does not approve supplements before sale, as its questions and answers on dietary supplements explain.
• No page gives a milligram figure for the capsule. Every amount on this site belongs to a named trial and says so.

Every number on this site belongs to one of four owners, and the page says which. A milligram figure is a published trial’s and names the trial. A price, a pack size or a shipping charge is the seller’s and carries the date it was read. A star score or an order count is the distributor’s summary. A cost per day or a saving between packs is the desk’s own arithmetic and shows its working.

Nothing is estimated to fill a gap. Where the label is silent, the page says the figure is not published rather than choosing one. The checkout is always the current price, and when it differs from a page, the checkout is right and the page is corrected.

The 4.7 average, the 951 written reviews, the 9,316 orders and the eight named buyers on the reviews page all come from the distributor. The desk did not collect them and cannot match them to real orders, so each page that shows them labels them as the distributor’s figures, and the lower-rated lines are printed beside the five-star ones.

The verdict table on the home page is a different thing: the desk’s own scores, row by row, with the reason beside each row, labelled as the desk’s judgement rather than a customer rating.